133 related articles for article (PubMed ID: 38127828)
1. Role of Apparent Diffusion Coefficient Map-Based First- and High-Order Radiomic Features for the Discrimination of Sacral Chordomas and Chondrosarcomas With Overlapping Conventional Imaging Features.
Amini B; Chenglei L; Duran-Sierra E; Wang WL; Canjirathinkal MA; Moradi H; Green WN; Madewell JE; Costelloe CM; Murphy WA; Valenzuela RF
JCO Precis Oncol; 2023 Sep; 7():e2300243. PubMed ID: 38127828
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic accuracy of DW MR imaging in the differentiation of chordomas and chondrosarcomas of the skull base: A 3.0-T MRI study of 105 cases.
Welzel T; Meyerhof E; Uhl M; Huang K; von Deimling A; Herfarth K; Debus J
Eur J Radiol; 2018 Aug; 105():119-124. PubMed ID: 30017267
[TBL] [Abstract][Full Text] [Related]
3. Is there a role for conventional MRI and MR diffusion-weighted imaging for distinction of skull base chordoma and chondrosarcoma?
Müller U; Kubik-Huch RA; Ares C; Hug EB; Löw R; Valavanis A; Ahlhelm FJ
Acta Radiol; 2016 Feb; 57(2):225-32. PubMed ID: 25722460
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of cranial nerve involvement in chordomas and chondrosarcomas: a retrospective imaging study.
Oura T; Shimono T; Horiuchi D; Goto T; Takita H; Tsukamoto T; Tatekawa H; Ueda D; Matsushita S; Mitsuyama Y; Atsukawa N; Miki Y
Neuroradiology; 2024 Feb; ():. PubMed ID: 38407581
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of Skull Base Chondrosarcomas, Chordomas, and Metastases: Utility of DWI and Dynamic Contrast-Enhanced Perfusion MR Imaging.
Ota Y; Liao E; Capizzano AA; Baba A; Kurokawa R; Kurokawa M; Srinivasan A
AJNR Am J Neuroradiol; 2022 Sep; 43(9):1325-1332. PubMed ID: 35953276
[TBL] [Abstract][Full Text] [Related]
6. Analysis of radiological features relative to histopathology in 42 skull-base chordomas and chondrosarcomas.
Pamir MN; Ozduman K
Eur J Radiol; 2006 Jun; 58(3):461-70. PubMed ID: 16631334
[TBL] [Abstract][Full Text] [Related]
7. Cancer Radiomic and Perfusion Imaging Automated Framework: Validation on Musculoskeletal Tumors.
Sierra ED; Valenzuela R; Canjirathinkal MA; Costelloe CM; Moradi H; Madewell JE; Murphy WA; Amini B
JCO Clin Cancer Inform; 2024 Jan; 8():e2300118. PubMed ID: 38181324
[TBL] [Abstract][Full Text] [Related]
8. Chondrosarcoma and Chordoma of the Skull Base and Spine: Implication of Tumor Location on Patient Survival.
Vuong HG; Dunn IF
World Neurosurg; 2022 Jun; 162():e635-e639. PubMed ID: 35339711
[TBL] [Abstract][Full Text] [Related]
9. Distinguishing chordoid meningiomas from their histologic mimics: an immunohistochemical evaluation.
Sangoi AR; Dulai MS; Beck AH; Brat DJ; Vogel H
Am J Surg Pathol; 2009 May; 33(5):669-81. PubMed ID: 19194275
[TBL] [Abstract][Full Text] [Related]
10. Radiomic analysis of multiparametric magnetic resonance imaging for differentiating skull base chordoma and chondrosarcoma.
Li L; Wang K; Ma X; Liu Z; Wang S; Du J; Tian K; Zhou X; Wei W; Sun K; Lin Y; Wu Z; Tian J
Eur J Radiol; 2019 Sep; 118():81-87. PubMed ID: 31439263
[TBL] [Abstract][Full Text] [Related]
11. Cartilaginous tumors and chordomas of the cranial base.
Weber AL; Brown EW; Hug EB; Liebsch NJ
Otolaryngol Clin North Am; 1995 Jun; 28(3):453-71. PubMed ID: 7675464
[TBL] [Abstract][Full Text] [Related]
12. Chondroid chordomas and low-grade chondrosarcomas of the craniospinal axis. An immunohistochemical analysis of 17 cases.
Wojno KJ; Hruban RH; Garin-Chesa P; Huvos AG
Am J Surg Pathol; 1992 Dec; 16(12):1144-52. PubMed ID: 1463093
[TBL] [Abstract][Full Text] [Related]
13. Predictive role of Apparent Diffusion Coefficient (ADC) from Diffusion Weighted MRI in patients with sacral chordoma treated with carbon ion radiotherapy (CIRT) alone.
Preda L; Casale S; Fanizza M; Fiore MR; Viselner G; Paganelli C; Buizza G; Fontana G; Vitolo V; Barcellini A; Baroni G; Fossati P; Valvo F
Eur J Radiol; 2020 May; 126():108933. PubMed ID: 32171109
[TBL] [Abstract][Full Text] [Related]
14. Revisitation of imaging features of skull base chondrosarcoma in comparison to chordoma.
Hasegawa H; Shin M; Niwa R; Koizumi S; Yoshimoto S; Shono N; Shinya Y; Takami H; Tanaka S; Umekawa M; Amemiya S; Kin T; Saito N
J Neurooncol; 2022 Sep; 159(3):581-590. PubMed ID: 35882753
[TBL] [Abstract][Full Text] [Related]
15. Long-term clinical outcomes following en bloc resections for sacral chordomas and chondrosarcomas: a series of twenty consecutive patients.
Hsieh PC; Xu R; Sciubba DM; McGirt MJ; Nelson C; Witham TF; Wolinksy JP; Gokaslan ZL
Spine (Phila Pa 1976); 2009 Sep; 34(20):2233-9. PubMed ID: 19752710
[TBL] [Abstract][Full Text] [Related]
16. Operative nuances and surgical limits of the endoscopic approach to clival chordomas and chondrosarcomas: A single-center experience of 72 patients.
Ceylan S; Emengen A; Caklili M; Ergen A; Yılmaz E; Uzuner A; Icli D; Cabuk B; Anik I
Clin Neurol Neurosurg; 2021 Sep; 208():106875. PubMed ID: 34388599
[TBL] [Abstract][Full Text] [Related]
17. Gamma Knife surgery for intracranial chordoma and chondrosarcoma: radiosurgical perspectives and treatment outcomes.
Kim JH; Jung HH; Chang JH; Chang JW; Park YG; Chang WS
J Neurosurg; 2014 Dec; 121 Suppl():188-97. PubMed ID: 25434952
[TBL] [Abstract][Full Text] [Related]
18. Differentiating skull base chordomas and invasive pituitary adenomas with conventional MRI.
Gao A; Bai J; Cheng J; Cheng X; Li S; Zhang Z; Zhang Y
Acta Radiol; 2018 Nov; 59(11):1358-1364. PubMed ID: 29448805
[TBL] [Abstract][Full Text] [Related]
19. [Pathology of myxoid bone tumors of the skull base].
Gavril C; Bouvier C; Liprandi A; Dufour H; Peragut JC; Zanaret M; Figarella-Branger D
Ann Pathol; 2002 Sep; 22(4):259-66. PubMed ID: 12410148
[TBL] [Abstract][Full Text] [Related]
20. The role of apparent diffusion coefficient histogram metrics for differentiating pediatric medulloblastoma histological variants and molecular groups.
Gonçalves FG; Tierradentro-Garcia LO; Kim JDU; Zandifar A; Ghosh A; Viaene AN; Khrichenko D; Andronikou S; Vossough A
Pediatr Radiol; 2022 Dec; 52(13):2595-2609. PubMed ID: 35798974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
